UNSPSC 51283710: Cefuzonam

This classification denotes a cephalosporin antibiotic with the molecular formula C16H15N7O5S4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 860MT00T7T, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-((1,2,3-thiadiazol-5-ylthio)methyl)-, (6r-(6alpha,7beta(z)))- but generally known as cefuzonam, which bears US NIH Compound Identifier 6336505.

UNSPSC 51283710 Cefuzonam is a Commodity code that describes a specific antibiotic pharmaceutical product, yet the recent state and local opportunities tagged under it do not align with cefuzonam procurement itself. The Illinois Department of Public Health and Seminole County, Florida have posted or awarded contracts under this code for pharmaceutical inventory management and public health supply chains, but the actual products solicited — Doxycycline Hyclate, Ciprofloxacin Hydrochloride, Naloxone, and drug deactivation systems — fall outside cefuzonam's narrow scope. State and local procurement offices, particularly health departments and county public health agencies, are using this code to tag pharmaceutical warehouse and emergency-response supply contracts, suggesting a broader tagging practice around antibiotic and emergency-pharmaceutical categories rather than cefuzonam specifically.

The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract to Chartwell Rx LLC on August 28, 2026, for a 12-month initial term with two optional renewal years through the MMCAP Infuse cooperative purchasing consortium; the IFB process resulted in a completed award for Doxycycline and Ciprofloxacin distribution. Seminole County, Florida posted an IFB on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, though the due date listed (July 26, 2023) appears outdated relative to the posting date. Both opportunities reflect health department and county public health operations in the Southeast and Midwest. Entities pursuing contracts under this code should verify with issuing agencies that the actual pharmaceutical products match their capabilities, as recent activity shows systematic mislabeling of pharmaceutical supply-chain procurements under the cefuzonam commodity code.